Semin Neurol 2001; 21(3): 269-274
DOI: 10.1055/s-2001-17944
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Prenatal Diagnosis of Disorders of Energy Metabolism

Brian H. Robinson
  • Head, Metabolism Research Programme, Research Institute, Hospital for Sick Children, and Departments of Paediatrics and Biochemistry, University of Toronto, Ontario, Canada
Further Information

Publication History

Publication Date:
18 October 2001 (online)

ABSTRACT

Prenatal diagnosis for disorders of energy metabolism is problematic because of the lack of information about the efficacy of the procedures currently employed. Difficulties arise due to uncertainty as to the nuclear or mitochondrial DNA origin of respiratory chain abnormalities, and also as to the tissue specificity of defective gene expression. Here, we look at the current experience with prenatal diagnosis of these disorders and examine possible future directions.

REFERENCES

  • 1 Lissens W, De Meirleir L, Seneca S. Mutations in the X-linked pyruvate dehydrogenase (E1) α subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.  Hum Mutat . 2000;  15 209-219
  • 2 Rouillac C, Aral B, Fouque F. First prenatal diagnosis of defects in the HsPDX1 gene encoding protein X, an additional lipoyl-containing subunit of the human pyruvate dehydrogenase complex.  Prenat Diagn . 1999;  19 1160-1164
  • 3 Robinson B H, Toone J R, Petrova-Benedict R, Dimmick J E, Oei J, Applegarth D A. Prenatal diagnosis of pyruvate carboxylase deficiency.  J Prenat Diagn . 1985;  5 67-71
  • 4 Van Coster N R, Janssens S, Misson J P, Verloes A, Leroy J G. Prenatal diagnosis of pyruvate carboxylase deficiency by direct measurement of catalytic activity on chorionic villi samples.  Prenat Diagn . 1998;  18 1041-1044
  • 5 Robinson B H, Glerum D M, Chow W, Petrova-Benedict R, Lightowlers R, Capaldi R. The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia.  Pediatr Res . 1990;  28 549-555
  • 6 Morris A MM, Leonard J V, Brown G K. Deficiency of respiratory chain complex I is a common cause of Leigh disease.  Ann Neurol . 1996;  40 25-30
  • 7 Loeffen J L, Smeitink J A, Trijbels J M. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects.  Hum Mutat . 2000;  15 123-134
  • 8 Bourgeron T, Rustin P, Chretien D. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.  Nature Genet . 1995;  11 144-149
  • 9 Zhu Z, Yao J, Johns T. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome.  Nature Genet . 1998;  20 337-343
  • 10 Tiranti V, Hoertnagel K, Carrozzo R. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency.  Am J Hum Genet. 1998;  63 1609-1621
  • 11 Lee H RN, Rioux J D, Daly M J. Genetic mapping of Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency [abstract #1711].  Am J Hum Genet . 1998;  63 A296
  • 12 Valnot I, von Kleist-Retzow C J. Barrientos A, et al.  A mutation in the human heme A:farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum Molec Genet . 2000;  9 1245-1249
  • 13 Papadopoulou L C, Sue C M, Davidson M M. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene.  Nature Genet . 1999;  23 333-337
  • 14 Merante F, Petrova-Benedict R, MacKay N. A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Québec.  Am J Hum Genet . 1993;  53 481-487
  • 15 Wanders R JA, Wijburg F A, Ruiter J. Prenatal diagnosis of systemic disorders of the respiratory chain in cultured amniocytes and chorionic villus fibroblasts by studying the formation of lactate and pyruvate.  J Inher Metab Dis . 1992;  15 84-91
  • 16 Houstek J, Kelement P, Hermanska J. Complex approach to prenatal diagnosis of cytochrome c oxidase deficiencies.  Prenat Diagn . 1999;  19 552-558
  • 17 Bodnar A G, Cooper J M, Holt I J, Leonard J V, Schapira A H. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion.  Am J Hum Genet . 1993;  53 663-669
  • 18 Kaukonen J, Juselius J K, Tiranti V. Role of adenine nucleotide translocator 1 in mtDNA maintenance.  Science . 2000;  289 782-785
  • 19 Marchington D R, Macaulay V, Hartshorne G M, Barlow D, Poulton J. Evidence from human oocytes for a genetic bottleneck in an mtDNA disease.  Am J Hum Genet . 1998;  63 769-775
  • 20 Chinnery P F, Howell N, Lightowlers R N, Turnbull D M. MELAS and MERRF: the relationship between maternal mutation load and the frequency of affected offspring.  Brain . 1997;  120 1713-1721
  • 21 Tatuch Y, Christodoulou J, Feigenbaum A. Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.  Am J Hum Genet . 1992;  50 852-858
  • 22 Tatuch Y, Robinson B H. The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria.  Biochem Biophys Res Comm . 1993;  192 124-128
  • 23 Tatuch Y, Pagon R A, Vlcek B, Roberts R, Korson M, Robinson B H. The 8993 mtDNA mutation: heteroplasmy and clinical presentation in three families.  Eur J Hum Genet . 1994;  2 35-43
  • 24 Trounce I, Neill S, Wallace D C. Cytoplasmic transfer of the mtDNA nt8993 T→G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio.  Proc Natl Acad Sci U S A . 1994;  91 8334-8338
  • 25 Garcia J J, Ogilvie I, Robinson B H, Capaldi R A. Structure, functioning and assembly of the ATP synthase in cells from patients with the T8993G mitochondrial DNA mutation. Comparison with the enzyme in Rho0 cells completely lacking mtDNA.  J Biol Chem . 2000;  275 11075-11081
  • 26 White S L, Shanske S, McGill J J. Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue or age related variation.  J Inher Metab Dis . 1999;  22 899-914
  • 27 White S L, Collins V R, Wolfe R. Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.  Am J Hum Genet . 1999;  65 474-482
  • 28 White S L, Shanske S, Biros I, Dahl H-HM, Thorburn D R, Di Mauro S. Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA.  Prenat Diagn . 1999;  19 1165-1168